Variable | Quintile 1 | Quintile 2 | Quintile 3 | Quintile 4 | Quintile 5 |
---|---|---|---|---|---|
Black Adults | Â | Â | Â | Â | Â |
Obese (BMI > =30) | 1.27 (1.02,1.58) | 1.25 (1.01,1.57) | 1.21 (0.96,1.51) | 1.07 (0.85,1.35) | Reference |
High waist circumference (>102Â cm (>40 in) for men; > 88Â cm (>35 in) for women | 1.23 (0.98,1.55) | 1.25 (0.99,1.57) | 1.25 (0.99,1.58) | 1.05 (0.83,1.33) | Reference |
High triglycerides (>150Â mg/dL) | 1.30 (0.95,1.77) | 1.27 (0.93,1.74) | 1.28 (0.93, 1.75) | 1.06 (0.76,1.48) | Reference |
Low HDL (for men <40 mg/dL, for women < 50 mg/dL or on lipid lowering medication) | 1.38 (1.09,1.76) | 1.27 (1.00,1.61) | 1.28 (1.00,1.63) | 1.07 (0.83,1.38) | Reference |
Blood pressure > 130/> 85 mm Hg or on antihypertensive medications | 1.34 (1.07,1.68) | 1.32 (1.05,1.66) | 1.20 (0.95,1.51) | 1.09 (0.86,1.38) | Reference |
High fasting glucose > 110 mg/dL or on antidiabetic medications | 1.41 (1.10,1.79) | 1.41 (1.11,1.80) | 1.29 (1.01,1.65) | 1.12 (0.87,1.45) | Reference |
Metabolic syndrome | 1.19 (0.91,1.57) | 1.19 (0.90,1.57) | 1.18 (0.89,1.57) | 0.96 (0.71,1.29) | Reference |
Inflammation (CRP ≥ 3 mg/L) | 1.36 (1.09,1.70) | 1.23 (0.98,1.54) | 1.21 (0.97,1.52) | 1.17 (0.93,1.48) | Reference |
Metabolic syndrome with inflammation | 1.52 (1.20,1.92) | 1.39 (1.10,1.77) | 1.36 (1.07,1.74) | 1.13 (0.88,1.45) | Reference |
White Adults | Â | Â | Â | Â | Â |
Obese (BMI > =30) | 1.69 (1.44,1.98) | 1.69 (1.48,1.92) | 1.40 (1.24,1.58) | 1.21 (1.08,1.36) | Reference |
High waist circumference (>102Â cm (>40 in) for men; > 88Â cm (>35 in) for women | 1.58 (1.36,1.84) | 1.59 (1.40,1.80) | 1.44 (1.29,1.61) | 1.29 (1.16,1.44) | Reference |
High triglycerides (>150Â mg/dL) | 1.20 (1.03,1.41) | 1.20 (1.05,1.36) | 1.27 (1.13,1.42) | 1.13 (1.01,1.27) | Reference |
Low HDL (for men <40 mg/dL, for women < 50 mg/dL or on lipid lowering medication) | 1.44 (1.23,1.67) | 1.46 (1.28,1.67) | 1.41 (1.26,1.59) | 1.37 (1.23,1.53) | Reference |
Blood pressure > 130/> 85 mm Hg or on antihypertensive medications | 1.13 (0.97,1.31) | 1.20 (1.06,1.36) | 1.14 (1.02,1.28) | 1.14 (1.03,1.26) | Reference |
High fasting glucose > 110 mg/dL or on antidiabetic medications | 1.58 (1.32,1.89) | 1.43 (1.23,1.67) | 1.32 (1.15,1.52) | 1.07 (0.93,1.22) | Reference |
Metabolic syndrome | 1.78 (1.50,2.12) | 1.62 (1.39,1.88) | 1.56 (1.36,1.79) | 1.38 (1.21,1.57) | Reference |
Inflammation (CRP≥3 mg/L) | 1.25 (1.07,1.45) | 1.37 (1.21,1.56) | 1.19 (1.06,1.35) | 1.17 (1.05,1.31) | Reference |
Metabolic syndrome with inflammation | 1.65 (1.41,1.93) | 1.67 (1.46,1.91) | 1.55 (1.37,1.75) | 1.37 (1.22,1.54) | Reference |